Naim Zaki

Long-Term Safety and Maintenance of Response With Esketamine Nasal Spray in Participants With Treatment-Resistant Depression: Interim Results of the SUSTAIN-3 Study

Naim Zaki, Li Chen, Rosanne Lane et al. · Neuropsychopharmacology · 2023 · 120 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy with esketamine in treatment-resistant depression: long-term extension study

Naim Zaki, Li Chen, Rosanne Lane et al. · The International Journal of Neuropsychopharmacology · 2025 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study

Meredith Castro, Samuel T. Wilkinson, Rayan K. Al Jurdi et al. · CNS Drugs · 2023 · 23 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies

Kathleen Kelly, Panna Sanga, Naim Zaki et al. · Current Medical Research and Opinion · 2019 · 21 citations

Medicine, Orthopedic Surgery, Pharmacotherapy +16

Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Neal E. Slatkin, Naim Zaki, Steven Wang et al. · Journal of Pain · 2018 · 15 citations

Medicine, Oncology, Pharmacology +14